Antihyperglycemic activity of Catharanthus roseus leaf powder in streptozotocin-induced diabetic rats

Abstract

Catharanthus roseus Linn (Apocynaceae), is a traditional medicinal plant used to control diabetes, in various regions of the world. In this study we evaluated the possible antidiabetic and hypolipidemic effect of C. roseus (Catharanthus roseus) leaf powder in diabetic rats. Diabetes was induced by intraperitoneal injection of streptozotocin (STZ, 55 mg/kg body wt) to male Wistar rats. The animals were divided into four groups: Control, control-treated, diabetic, and diabetic-treated group. Diabetic-treated and control-treated rats were treated with C. roseus leaf powder suspension in 2 ml distilled water, orally (100 mg/kg body weight/day/60 days). In diabetic rats (D-group) the plasma glucose was increased and the plasma insulin was decreased gradually. In the diabetic-treated group lowering of plasma glucose and an increase in plasma insulin were observed after 15 days and by the end of the experimental period the plasma glucose had almost reached the normal level, but insulin had not. The significant enhancement in plasma total cholesterol, triglycerides, LDL and VLDL-cholesterol, and the atherogenic index of diabetic rats were normalized in diabetic-treated rats. Decreased hepatic and muscle glycogen content and alterations in the activities of enzymes of glucose metabolism (glycogen phosphorylase, hexokinase, phosphofructokinase, pyruvate kinase, and glucose-6-phosphate dehydrogenase), as observed in the diabetic control rats, were prevented with C. roseus administration. Our results demonstrated that C. roseus with its antidiabetic and hypolipidemic properties could be a potential herbal medicine in treating diabetes.

Keywords: Anti Catharanthus roseus; STZ-induced diabetes; plasma insulin; plasma lipids.

Figure 1

Mean body weight of C, C + CR, D, and D + CR groups during the experimental period. Values are ± S.E., (n = 8 animals). Values not sharing common letters differ significantly at P < 0.05 (D.M.R test) among four experimental groups during the corresponding period.

Figure 2

Mean plasma glucose of C, C + CR, D, and D + CR groups during the experimental period. Values are ± S.E., (n = 8 animals). Values not sharing common letters differ significantly at P < 0.05 (D.M.R test) among four experimental groups during the corresponding period.

Figure 3

Mean plasma insulin of C, C + CR, D, and D + CR groups during the experimental period. Values are ± S.E., (n = 8 animals). Values not sharing common letters differ significantly at P < 0.05 (D.M.R test) among four experimental groups during the corresponding period.